Want to join the conversation?
Pharmaceutical company $AGN has operations in more than 100 countries. $AGN has development and manufacturing capabilities for raw material and active pharmaceutical ingredients and intermediate ingredients to support R&D internal product development efforts in its San Jose, California, Coleraine, Northern Ireland and Ambernath, India facilities.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?